Joslin identifies immune cells that promote growth of beta cells in type 1 diabetes

Provides new insights into type 1 diabetes pathology

2013-09-27

(Press-News.org) BOSTON - (September 27, 2013) - Joslin researchers have identified immune cells that promote growth of beta cells in type 1 diabetes. This study provides further evidence of a changed role for immune cells in type 1 diabetes pathology. The study appears online today and will also appear in the January issue of Diabetes.

In type 1 diabetes, the immune system infiltrates pancreatic islets and destroys insulin-producing beta cells. However, previous studies in non-obese diabetic (NOD) mice have suggested that immune cells can also contribute to preserving beta cells. This notion is strengthened by the observation by Joslin researchers who reported that members of the Center's 50-Year Medalist Study, who have lived with type 1 diabetes for 50 years or more, retain some beta cells and produce insulin.

"The traditional view of type 1 diabetes was that immune cells killed all beta cells and people with the disease would have to take insulin for life. But we know that some beta cells do survive and secrete insulin even when the patients have had type 1 diabetes for 50 years," says senior author Rohit N. Kulkarni, M.D., Ph.D., a Senior Investigator in the Section on Islet Cell and Regenerative Biology at Joslin and Associate Professor of Medicine at Harvard Medical School.

In this study, Joslin researchers were interested in learning exactly how immune cells could promote beta cell growth and identifying the type of cell and the mechanisms underlying this effect.

In a series of experiments, the researchers injected NOD mice with immune cells from the pancreatic islets of donor NOD mice and assessed their effects on beta cells. The immune cells tested included subtypes of B or T immune cells.

The researchers found that it is T cells not B cells that are associated with beta cell proliferation. Mice that received B cells showed no difference in beta cell growth. Mice that received the T cell subtypes CD4+ and CD8+ showed an elevation in all markers of beta cell proliferation compared to mice that did not receive them. The researchers also found that beta cell growth happens after islets are infiltrated by immune cells and is independent of the effects of glucose and insulin.

Further experiments with cell cultures showed that CD4+ and CD8+ cells secrete inflammatory cytokines and chemokines (Interleukin 2, Interleukin 6, Interleukin 10, MIP-1α and RANTES), which together enhanced beta cell proliferation. This is the first study to report that this group of "soluble factors" is involved in promoting beta cell growth.

"This gives us new insights into what is happening in the pathology of type 1 diabetes. The immune cells we identified send signals which appear to protect and promote growth of beta cells. This opens up an exciting new area that scientists have thought about; now we have the hard data to substantiate it," says Dr. Kulkarni.

The next step is to investigate the effects of immune cells on human beta cell growth. The factors secreted from CD4+ and CD8+ cells are potential therapeutic candidates to enhance beta cell growth to prevent or delay the onset of type 1 diabetes.

"We need to learn more about the relationship of beta cell death and proliferation to determine if we can harness these soluble substances to encourage beta cell proliferation rather than destruction," says Dr. Kulkarni.

INFORMATION:

This study was funded by the Juvenile Diabetes Research Foundation, National Institutes of Health and the Turkish Diabetes, Obesity and Nutrition Association.

About Joslin Diabetes Center

Joslin Diabetes Center, based in Boston, Massachusetts, undertakes diabetes research, clinical care, education and health and wellness programs on a global scale. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real progress in preventing and curing diabetes . Joslin is an independent, nonprofit institution affiliated with Harvard Medical School, and is recognized worldwide for driving innovative solutions in diabetes prevention, research, education, and care.

Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications. For more information, visit http://www.joslin.org

About Joslin Research

Joslin Research comprises the most comprehensive and productive effort in diabetes research under one roof anywhere in the world. With 30-plus faculty-level investigators, Joslin researchers focus on unraveling the biological, biochemical and genetic processes that underlie the development of type 1 and type 2 diabetes and related complications.

Joslin research is highly innovative and imaginative, employing the newest tools in genetics, genomics and proteomics to identify abnormalities that may play a role in the development of diabetes and its complications. Joslin Clinic patients, and others with diabetes, have the option of participating in clinical trials at Joslin to help translate basic research into treatment innovations. Joslin has one of the largest diabetes training programs in the world, educating 150 M.D. and Ph.D. researchers each year, many of whom go on to head diabetes initiatives at leading institutions all over the globe. For more information, visit http://www.joslinresearch.org.

ELSE PRESS RELEASES FROM THIS DATE:

Study: New medical device extremely effective at preventing HIV in women

2013-09-27

It's often said that the HIV/AIDS epidemic has a woman's face. The proportion of women infected with HIV has been on the rise for a decade; in sub-Saharan Africa, women constitute 60 percent of people living with disease. While preventative drugs exist, they have often proven ineffective, especially in light of financial and cultural barriers in developing nations. A new intravaginal ring filled with an anti-retroviral drug could help. Developed with support from the National Institute of Allergy and Infectious Diseases by Northwestern University visiting associate professor ...

Oncogenic signatures mapped in TCGA a guide for the development of personalized therapy

2013-09-27

New York, September 27, 2013 -- Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper from researchers at Memorial Sloan-Kettering Cancer Center published on September 26 in Nature Genetics supports a new approach: one based on the genomic signature of a tumor rather than the tissue of origin in the body. It is well known that the emergence of cancer is a multi-step process, but because of the efforts of The Cancer Genome Atlas (TCGA), funded by the US National Institutes of Health, and other large-scale ...

Setting blurred images in motion improves perception

2013-09-27

Philadelphia, Pa. (September 26, 2013) - Blurred images that are unidentifiable as still pictures become understandable once the images are set in motion. That's because of a phenomenon called "optic flow"—which may be especially relevant as a source of visual information in people with low vision, reports a study 'With an Eye to Low Vision: Optic Flow Enables Perception Despite Image Blur' (published online ahead of print, September 3, 2013) in the October issue of Optometry and Vision Science official journal of the American Academy of Optometry. The journal is published ...

Study examines health of kidney donors

2013-09-27

Washington, DC (September 26, 2013) — The short-term risks associated with kidney donation are relatively modest, but because many donors have additional medical conditions, it is important to evaluate their ongoing health. That's the conclusion of a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). In more than a third of kidney transplantations performed in the United States, the transplanted organs come from live donors. Research suggests that there are minimal health consequences for donors, but only a few ...

NASA Mars rover Curiosity finds water in first sample of planet surface

2013-09-27

Troy, N.Y. – The first scoop of soil analyzed by the analytical suite in the belly of NASA's Curiosity rover reveals that fine materials on the surface of the planet contain several percent water by weight. The results were published today in Science as one article in a five-paper special section on the Curiosity mission. Rensselaer Polytechnic Institute Dean of Science Laurie Leshin is the study's lead author. "One of the most exciting results from this very first solid sample ingested by Curiosity is the high percentage of water in the soil," said Leshin. "About 2 ...

Wildlife face 'Armageddon' as forests shrink

2013-09-27

Singapore, 27 September 2013 – Species living in rainforest fragments could be far more likely to disappear than was previously thought, says an international team of scientists. In a study spanning two decades, the researchers witnessed the near-complete extinction of native small mammals on forest islands created by a large hydroelectric reservoir in Thailand. "It was like ecological Armageddon," said Luke Gibson from the National University of Singapore, who led the study. "Nobody imagined we'd see such catastrophic local extinctions." The study, just published ...

Pan-cancer studies find common patterns shared by different tumor types

2013-09-27

Cancer encompasses a complex group of diseases traditionally defined by where in the body it originates, as in lung cancer or colon cancer. This framework for studying and treating cancer has made sense for generations, but molecular analysis now shows that cancers of different organs have many shared features, while cancers from the same organ or tissue are often quite distinct. The Pan-Cancer Initiative, a major effort to analyze the molecular aberrations in cancer cells across a range of tumor types, has yielded an abundance of new findings reported in 18 forthcoming ...

How can supply of penicillin be an issue in any country in 2013?

2013-09-27

Benzathine penicillin G (BPG) is the most essential antibiotic for the treatment and prevention of group A streptococcal infections associated with rheumatic fever and rheumatic heart disease. Yet while some countries such as South Africa and Brazil have stable supplies, most countries with a high RHD burden often suffer interruptions in supply and also have quality control issues. The problems around supply of this drug are discussed in one of the papers of the RHD special issue of Global Heart, the journal of the World Heart Federation. The paper is by Dr Rosemary Wyber, ...

Rheumatic heart disease: A new era of pushing for global control as World Heart Day approaches

2013-09-27

As this year's World Heart Day approaches (Sunday September 29), focus is returning to a neglected and entirely preventable heart disease that largely affects the world's youngest and poorest populations: rheumatic heart disease (RHD). To highlight this long-neglected condition, Global Heart, the journal of The World Heart Federation (WHF) is publishing a special issue dedicated to RHD. The World Heart Federation views the publication of the special issue of Global Heart as a vital step in its target of reducing global RHD deaths in under 25s by 25% by 2025. Reducing ...

Increasing awareness that untreated sore throat can lead to rheumatic heart disease is a huge part of the battle

2013-09-27

Without a huge improvement in living conditions, a cure, or a vaccine, rheumatic heart disease (RHD) will continue to blight low-income and middle-income countries. Raising community awareness of the condition, emphasising that untreated sore throat caused by group A streptococcal (GAS) infection can lead to acute rheumatic fever (ARF)/RHD, is a huge part of the battle. The issues around advocacy and awareness are discussed in a paper in the RHD special issue of Global Heart, the journal of the World Heart Federation, written by Dr Liesl Zühlke, University of Cape Town ...

Joslin identifies immune cells that promote growth of beta cells in type 1 diabetes

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: